๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Portal Hypertension
Clinical trial register · China

Portal Hypertension Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 6 Guangzhou 4 Jinan 3 Chengdu 2 Shenyang 2
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai6 Guangzhou4 Jinan3 Chengdu2 Shenyang2
All 20 locations
Target enrolment
to

Portal Hypertension trials in China

20 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Coil-Assisted Small-Diameter Covered-Stent Shunt Reduction for Refractory Hepatic Encephalopathy After TIPS
NCT07799948Hepatic Encephalopathy, Transjugular Intrahepatic Portosystemic Shunt (TIPS), Portal Hypertension, Liver Cirrhosis
Air Force Military Medical University, China
Not applicable
30
Xi'an
2026-09-01
Not yet open
Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis
NCT07587671Liver Cirrhosis, Portal Hypertension, Gastroesophageal Varices Bleeding, Esophageal Varices
West China Hospital
Not applicable
240
Chengdu, Chongqing, Xiamen
2026-08-01
Not yet open
Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)
NCT07588334Cirrhosis, Liver, Splenectomy; Status, Portal Hypertension, Lipid Profiles
Northern Jiangsu People's Hospital
Observational
30
Yangzhou
2026-05-01
Recruiting
Treatment Outcomes for Portal Hypertension Esophageal and Gastric Varices
NCT07358663Esophagogastric Varices, Portal Hypertension
Shanghai Zhongshan Hospital
Observational
1,384
Shanghai
2026-01-20
Not yet open
TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal Hypertension
NCT07350070HCC, Liver Cirrhosis, Portal Hypertension
DrugTACE
Tongji Hospital
Phase 2
78
Fuzhou, Nanning, Taihe, Wuhan, Jinan, Qingdao
2025-12-31
Recruiting
Construction of a Portal Hypertension Biobank
NCT07419724Variceal Bleeding, Portal Hypertension
Shanghai Zhongshan Hospital
Observational
1,000
Shanghai
2025-10-16
Recruiting
Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis
NCT07116096Liver Cirrhosis, Portal Hypertension
Shanxi Provincial People's Hospital
Not applicable
120
Luoyang, Taiyuan
2025-08-17
Recruiting
A Study to Evaluate Splenectomy on Debridement for Acute Necrotizing Pancreatitis With Pancreatic Sinistral Portal Hypertension
NCT07080697Acute Necrotizing Pancreatitis, Portal Hypertension
Zhejiang University
Not applicable
66
Hangzhou
2025-07-30
Recruiting
Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension
NCT06970509Esophageal Varices, Portal Hypertension
Shanghai Zhongshan Hospital
Observational
1,450
Guangzhou, Nanchang, Shenyang, Jinan, Shanghai
2025-03-01
Recruiting
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
NCT06549673Portal Hypertension, Cirrhosis, Varices, Esophageal
Chinese University of Hong Kong
Observational
375
Guangzhou, Shanghai
2025-01-20
Recruiting
Noninvasive Prediction of Portal Hypertension in Cirrhosis Using Sound Touch Viscoelastography
NCT06316869Portal Hypertension, Cirrhosis
First Affiliated Hospital of Wenzhou Medical University
Observational
216
Wenzhou
2024-09-02
Not yet open
Efficacy and Safety of Intraparenchymal Portal Vein Covered Stents in Treating Portal Hypertension and Its Complications
NCT06320912Portal Hypertension
Shanghai Shenqi Medical Technology Co., Ltd
Not applicable
258
Guangzhou
2024-04-05
Recruiting
SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury
NCT06173947End Stage Liver Disease, Jaundice, Liver Dysfunction, Portal Hypertension
Nanfang Hospital, Southern Medical University
Observational
411
Guangzhou
2024-01-01
Not yet open
Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis
NCT06122753Portal Hypertension, Portal Vein Thrombosis, Esophageal Varix Bleeding, Portosystemic Shunt
West China Hospital
Not applicable
120
Chengdu
2024-01
Active, closed
A Digital Tongue Diagnosis Model for High- and Low-risk Esophagogastroduodenal Varices in Cirrhosis
NCT05979935Esophageal Varices, Liver Cirrhosis, Sublingual Varices, Portal Hypertension
Qilu Hospital of Shandong University
Observational
1,300
Jinan
2023-07-01
By invitation
The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot Study
NCT05508633Portal Hypertension
Shanghai Changzheng Hospital
Phase 2
20
Shanghai
2022-10-28
Recruiting
3D-MRE for Assessing Cirrhosis, Advanced Chronic Liver Disease and Portal Hypertension
NCT05475015Cirrhosis, Liver, Portal Hypertension, Advanced Chronic Liver Disease
Shengjing Hospital
Observational
150
Shenyang
2022-08-16
Recruiting
The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis Patients
NCT05325437Cirrhosis, Liver, Splenectomy; Status, Portal Hypertension
Northern Jiangsu People's Hospital
Not applicable
20
Yangzhou
2022-03-01
Active, closed
Effectiveness of Treatments for Cirrhosis With Varicose Veins
NCT06961474Esophageal Varices Bleeding, Portal Hypertension
Shanghai Zhongshan Hospital
Observational
1,900
Shanghai
2022-02-01
Recruiting
EUS Guided Portal-systemic Pressure Gradient Measurement
NCT04633356Portal Hypertension, Cirrhosis
Chinese University of Hong Kong
Phase 1/2
30
Hong Kong
2020-11-12
Rows per page Showing 1–20 of 20
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/portal-hypertension

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 20 of those studies listing the condition Portal Hypertension.

How many Portal Hypertension trials are recruiting in China?

12 of the 20 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 5 have not yet opened recruitment, 2 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Portal Hypertension), 20 studies
PhaseStudiesRecruitingShare
Observational10750%
Not applicable7435%
Phase 22010%
Phase 1/2115%

Most active sponsors

Lead sponsors with the most studies (Portal Hypertension)
Lead sponsorStudiesRecruiting
Shanghai Zhongshan Hospital43
Chinese University of Hong Kong22
Northern Jiangsu People's Hospital21
West China Hospital20
Air Force Military Medical University, China11
First Affiliated Hospital of Wenzhou Medical University11
Nanfang Hospital, Southern Medical University11
Qilu Hospital of Shandong University10
Shanghai Changzheng Hospital10
Shanghai Shenqi Medical Technology Co., Ltd10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.